Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Grass pollen allergoids - Allergopharma

Next Previous
X
Search
Drug Profile

Grass pollen allergoids - Allergopharma

Alternative Names: Allergovit 6 Grasses

Latest Information Update: 26 Sep 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Allergopharma
  • Class Allergens; Antiallergics; Plant allergy immunotherapies
  • Mechanism of Action Immunosuppressants; T lymphocyte modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Grass pollen hypersensitivity
  • Phase III Rhinoconjunctivitis; Seasonal allergic rhinitis

Most Recent Events

  • 26 Sep 2022 Grass pollen allergoids is still in phase II trial for Rhinoconjunctivitis and Seasonal allergic rhinitis in Germany, Poland, Spain (SC) (EudraCT2017-000754-19)
  • 26 Sep 2022 Grass pollen allergoids is still in phase-II clinical trials in Seasonal allergic rhinitis and Seasonal allergic rhinitis (In adolescents, In children, Treatment-experienced) in Poland, Spain (SC) (EudraCT2018-000548-25)
  • 12 Oct 2021 Allergopharma completes a phase II trial in Rhinoconjunctivitis with or without asthma (In adoloescents, In children, Treatment-experienced) in Germany, Poland, Russia and Spain

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top